Cargando…
Retraction Note: Comparison of two FDA-approved interspinous spacers for treatment of lumbar spinal stenosis: Superion versus X-STOP—a meta-analysis from five randomized controlled trial studies
Autores principales: | Zhao, He, Duan, Li-Jun, Gao, Yu-Shan, Yang, Yong-Dong, Zhao, Ding-Yan, Tang, Xiang-Sheng, Hu, Zhen-guo, Li, Chuan-Hong, Chen, Si-Xue, Liu, Tao, Yu, Xing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5987632/ https://www.ncbi.nlm.nih.gov/pubmed/29866198 http://dx.doi.org/10.1186/s13018-018-0845-7 |
Ejemplares similares
-
Comparison of two FDA-approved interspinous spacers for treatment of lumbar spinal stenosis: Superion versus X-STOP—a meta-analysis from five randomized controlled trial studies
por: Zhao, He, et al.
Publicado: (2018) -
Minimally Invasive Treatment of Moderate Lumbar Spinal Stenosis with the Superion(®) Interspinous Spacer
por: Bini, Walter, et al.
Publicado: (2011) -
Interspinous Process Decompression With The Superion(®) Spacer For Lumbar Spinal Stenosis: Real-World Experience From A Device Registry
por: Tekmyster, Gene, et al.
Publicado: (2019) -
Superion(®) InterSpinous Spacer for treatment of moderate degenerative lumbar spinal stenosis: durable three-year results of a randomized controlled trial
por: Patel, Vikas V, et al.
Publicado: (2015) -
Effects of interspinous spacers on lumbar degenerative disease
por: ZHOU, DONG, et al.
Publicado: (2013)